Hmm, so it seems they've chosen a synthetic product over natural because ...
"the Company will not be required to comply with the extensive testing and controls in the US Food and Drug Administration’s (FDA) “Guidance for Botanical Drug Products” that apply to natural cannabidiol extract based products."
... along with it being more consistent and pure. It's probably cheaper to manufacture also, which is good for the balance sheet.
However, my concern is that the whole point of using cannabis for medicinal purposes is to take advantage of it's natural qualities. Manufacturing a synthetic version of the real thing may be cheaper and easier to get FDA approved, but will it actually work???
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Secures Commercial-Scale Synthetic Cannabidiol-BOT.AX
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
2.94%
!
16.5¢

Ann: Botanix Secures Commercial-Scale Synthetic Cannabidiol-BOT.AX, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $323.5M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 16.0¢ | $3.657M | 21.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 180978 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 529694 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 180978 | 0.165 |
91 | 5063655 | 0.160 |
45 | 2610474 | 0.155 |
54 | 1922438 | 0.150 |
38 | 2758179 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 529694 | 12 |
0.175 | 2377047 | 28 |
0.180 | 2786998 | 58 |
0.185 | 2006385 | 35 |
0.190 | 1280195 | 22 |
Last trade - 16.18pm 28/07/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |